Zion Zibly, MD | |
15 Valley Dr Ste 201, Greenwich, CT 06831-5205 | |
(203) 737-2096 | |
Not Available |
Full Name | Zion Zibly |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 15 Valley Dr Ste 201, Greenwich, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346591609 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 57.020807 (Ohio) | Secondary |
207T00000X | Neurological Surgery | 72990 (Connecticut) | Primary |
Entity Name | Yale University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A study recently conducted by US Oncology and Aetna finds that evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes. The study, which compared patients treated with evidence-based guidelines (also known as ‘on pathway') to those treated with non-evidence-based guidelines (also known as ‘off pathway'), was published in the peer-reviewed Journal of Oncology Practice.
Michigan State University and University of Nebraska Medical Center researchers are refuting an earlier French government-funded study that claims titanium dioxide, a common food additive used worldwide, causes digestive inflammation and lesions in rats.
Amedica Corporation, a biomaterial company that develops and commercializes silicon nitride ceramics, today released the results of its CASCADE study, a blinded, randomized clinical trial that compared outcomes of spinal fusion surgery between its composite silicon nitride spacers manufactured with a central core of cancellous structured ceramic (CsC), to the gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft.
Christian Companion Senior Care, the nation's first senior care franchise to combine practical and spiritual assistance, is bringing its services to Charlotte.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Zion Zibly, MD 15 Valley Dr Ste 201, Greenwich, CT 06831-5205 Ph: () - | Zion Zibly, MD 15 Valley Dr Ste 201, Greenwich, CT 06831-5205 Ph: (203) 737-2096 |
News Archive
A study recently conducted by US Oncology and Aetna finds that evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes. The study, which compared patients treated with evidence-based guidelines (also known as ‘on pathway') to those treated with non-evidence-based guidelines (also known as ‘off pathway'), was published in the peer-reviewed Journal of Oncology Practice.
Michigan State University and University of Nebraska Medical Center researchers are refuting an earlier French government-funded study that claims titanium dioxide, a common food additive used worldwide, causes digestive inflammation and lesions in rats.
Amedica Corporation, a biomaterial company that develops and commercializes silicon nitride ceramics, today released the results of its CASCADE study, a blinded, randomized clinical trial that compared outcomes of spinal fusion surgery between its composite silicon nitride spacers manufactured with a central core of cancellous structured ceramic (CsC), to the gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft.
Christian Companion Senior Care, the nation's first senior care franchise to combine practical and spiritual assistance, is bringing its services to Charlotte.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
› Verified 1 days ago
Andrea F Douglas, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Valley Dr, Greenwich, CT 06831 Phone: 203-661-3333 Fax: 203-661-5610 | |
Paul Jon Apostolides, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
Mark H Camel, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
John G Strugar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 15 Valley Dr, Greenwich, CT 06831 Phone: 203-785-2807 Fax: 203-863-4496 | |
Scott L Simon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 | |
Amory J Fiore, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Greenwich Office Park, Greenwich, CT 06831 Phone: 203-869-1145 Fax: 203-618-1721 |